Press Releases Aequus Pharmaceuticals Inc.

Equities

AQS

CA0076361033

Market Closed - Toronto S.E. Other stock markets 03:49:19 2024-05-01 pm EDT			5-day change	1st Jan Change
0.01 ^CAD	-33.33%		-33.33%	-60.00%

2023	Aequus Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Aequus Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aequus Provides General Update and Fiscal 2023 Financial Results	Apr. 29	AQ
Aequus Reports Third Quarter 2023 Financial Highlights and General Update	Nov. 29	AQ
Aequus Announces New Financing	23-10-20	AQ
Aequus Announces New Financing and Provides Launch Update of Zimed Preservative Free (Bimatoprost 0.03%)	23-10-06	AQ
Aequus Reports Second Quarter 2023 Financial Highlights and General Update	23-08-29	GL
Aequus Announces Zimed PF Now Available in Canada	23-08-24	GL
Aequus Announces Zimed PF Website Launch	23-08-22	GL
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	23-08-21	AQ
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	23-08-18	GL
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	23-08-18	AQ
Aequus Announces Financing to Support Launch of Zimed Preservative Free	23-07-07	AQ
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)	23-07-06	GL
Aequus Provides General Update and First Quarter 2023 Financial Highlights	23-05-30	GL
Aequus Provides General Update and Fiscal 2022 Financial Results	23-05-01	GL
Aequus Grants Stock Options	23-04-19	GL
Aequus Grants Stock Options	23-04-19	AQ
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board Update	23-04-05	GL
Aequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)	22-12-20	GL
Aequus Reports Third Quarter 2022 Financial Highlights	22-11-29	GL
Aequus Announces Sandoz Contract Expiry at Year End and Expected Health Canada Approval for Zimed® PF (Preservative Free)	22-11-29	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Aequus Pharmaceuticals Inc.

Equities

AQS

CA0076361033

Press Releases

Filters